The World Health Organisation. Medicines shortages: global approaches to addressing shortages of essential medicines in health systems. WHO Drug Inf2016; 30: 180–185.
2.
ShukarSZahoorFHayatK, et al.Drug shortage: causes, impact, and mitigation strategies. Front Pharmacol2021; 12: 693426.
3.
HolcombeBMattoxTWPlogstedS. Drug shortages: effect on parenteral nutrition therapy. Nutr Clin Pract2018; 33: 53–61.
4.
WiseJ. Why are there shortages of HRT and other drugs in the UK?Br Med J2022; 377: o1183.
LevêqueD. Generic drugs in oncology. Lancet Oncol2017; 18: e63.
9.
McBrideAHudson-DiSalleSPilzJ, et al.National survey on the effect of oncology drug shortages in clinical practice: a hematology oncology pharmacy association survey. JCO Oncol Pract2022; 18: e1289–e1296.
10.
OvezmyradovB. Product availability and stockpiling in times of pandemic: causes of supply chain disruptions and preventive measures in retailing. Ann Oper Res2022; 318: 1–33.
11.
Milne-IvesMLamCvan VelthovenM,et al.The impact of Brexit on the pharmaceutical supply chain of the United Kingdom: scoping review protocol. JMIR Res Protoc2020; 9: e17684.
12.
WuS. Effect of the escalating China-US trade war on health care. Lancet2019; 394: 1140.
YabroffKRMariottoATangkaF, et al.Annual report to the nation on the Status of cancer, part 2: patient economic burden associated with cancer care. J Natl Cancer Inst2021; 113: 1670–1682.
FahrenbruchRKintzelPBottAM, et al.Dose rounding of biologic and cytotoxic anticancer agents: a position statement of the hematology/oncology pharmacy association. J Oncol Pract2018; 14: e130–e136.
23.
PrintzC. Medication shortages threaten cancer care: the oncology community and the FDA tackle ongoing drug shortage problem. Cancer2012; 118: 289–291.